Insight Molecular Diagnostics (IMDX) EBT Margin Growth (1y) (2021 - 2026)
Insight Molecular Diagnostics (IMDX) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 617.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 948.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 665.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -115.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 163.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -646.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 288.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 172.00 |
| 10 | Insight Molecular Diagnostics | 158.03 Mn | 139.50 Mn | 157,000.00 | -287,071.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -287,071.00 |
| Mar 31, 2026 | -2.81 Mn |
| Dec 31, 2025 | 20,541.00 |
| Sep 30, 2025 | 750,294.00 |
| Jun 30, 2025 | 286,058.00 |
| Mar 31, 2025 | 486,892.00 |
| Dec 31, 2024 | 283,007.00 |
| Sep 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -296,079.00 |
| Mar 31, 2024 | -719,333.00 |
| Dec 31, 2023 | -367,756.00 |
| Sep 30, 2023 | -132,122.00 |
| Jun 30, 2023 | -172,525.00 |
| Mar 31, 2023 | 233,331.00 |
| Dec 31, 2022 | -41,827.00 |
| Sep 30, 2022 | 121,107.00 |
| Jun 30, 2022 | 53,074.00 |
| Mar 31, 2022 | 69,470.00 |
| Dec 31, 2021 | 28,873.00 |
| Sep 30, 2021 | -18,028.00 |